Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$52.83 - $78.22 $1,056 - $1,564
20 Added 0.3%
6,713 $517,000
Q3 2023

Nov 09, 2023

SELL
$67.52 - $89.42 $4,186 - $5,544
-62 Reduced 0.92%
6,693 $455,000
Q2 2023

Aug 14, 2023

BUY
$73.76 - $85.98 $146,044 - $170,240
1,980 Added 41.47%
6,755 $551,000
Q1 2023

May 12, 2023

SELL
$71.62 - $86.62 $142,380 - $172,200
-1,988 Reduced 29.4%
4,775 $354,000
Q4 2022

Feb 08, 2023

BUY
$80.67 - $352.29 $478,776 - $2.09 Million
5,935 Added 716.79%
6,763 $560,000
Q3 2022

Nov 14, 2022

BUY
$282.54 - $391.85 $20,060 - $27,821
71 Added 9.38%
828 $235,000
Q2 2022

Aug 12, 2022

SELL
$322.67 - $449.65 $57,757 - $80,487
-179 Reduced 19.12%
757 $262,000
Q1 2022

May 13, 2022

BUY
$353.85 - $487.79 $331,203 - $456,571
936 New
936 $405,000
Q2 2021

Aug 13, 2021

SELL
$387.35 - $450.26 $2.51 Million - $2.92 Million
-6,481 Closed
0 $0
Q4 2020

Feb 08, 2021

SELL
$246.9 - $321.87 $38,269 - $49,889
-155 Reduced 2.34%
6,481 $2.06 Million
Q3 2020

Oct 30, 2020

SELL
$232.22 - $282.96 $160,928 - $196,091
-693 Reduced 9.46%
6,636 $1.64 Million
Q2 2020

Jul 31, 2020

BUY
$185.43 - $279.56 $1.36 Million - $2.05 Million
7,329 New
7,329 $1.94 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.4B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Prudential PLC Portfolio

Follow Prudential PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential PLC, based on Form 13F filings with the SEC.

News

Stay updated on Prudential PLC with notifications on news.